You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tetrahydrouridine

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tetrahydrouridine?

Tetrahydrouridine is an investigational drug.

There have been 17 clinical trials for Tetrahydrouridine. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2009.

The most common disease conditions in clinical trials are Lung Neoplasms, Head and Neck Neoplasms, and Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), EpiDestiny, Inc., and Yogen Saunthararajah.

Recent Clinical Trials for Tetrahydrouridine
Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult SubjectsEpiDestiny, Inc.Phase 1
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell DiseaseNational Institutes of Health (NIH)Phase 1
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell DiseaseEpiDestiny, Inc.Phase 1

See all Tetrahydrouridine clinical trials

Clinical Trial Summary for Tetrahydrouridine

Top disease conditions for Tetrahydrouridine
Top clinical trial sponsors for Tetrahydrouridine

See all Tetrahydrouridine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.